Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - Cash on Hand
Cash on Hand as of December 2023 : $0.77 B
According to Agios Pharmaceuticals
's latest financial reports the company has $0.77 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Agios Pharmaceuticals - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.77 B | -0.79% |
| 2022-12-31 | $0.78 B | -23.22% |
| 2021-12-31 | $1.02 B | 78.04% |
| 2020-12-31 | $0.57 B | 1.43% |
| 2019-12-31 | $0.56 B | -3.49% |
| 2018-12-31 | $0.58 B | 38.06% |
| 2017-12-31 | $0.42 B | -21.68% |
| 2016-12-31 | $0.54 B | 70.76% |
| 2015-12-31 | $0.31 B | -7.33% |
| 2014-12-31 | $0.34 B | 105.11% |
| 2013-12-31 | $0.16 B | 30.31% |
| 2012-12-31 | $0.12 B | -28.57% |
| 2011-12-31 | $0.17 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 1,533.36% | 🇺🇸 USA |
 Eli Lilly LLY | $2.58 B | 232.89% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.17 B | 566.08% | 🇬🇧 UK |
 Xencor XNCR | $0.59 B | -23.58% | 🇺🇸 USA |
 Exelixis EXEL | $0.96 B | 23.98% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.04 B | 34.71% | 🇺🇸 USA |